Patent: 10,040,859
✉ Email this page to a colleague
Summary for Patent: 10,040,859
Title: | Methods of treating hemophagocytic lymphohistiocytosis with an IL-33 receptor antibody |
Abstract: | Compositions and methods for treating a cytokine release syndrome such as chimeric antigen receptor T-cell cytokine release syndrome or hemophagocytic lymphohistiocytosis are provided. |
Inventor(s): | Behrens; Edward M. (West Chester, PA), Rood; Julia E. (Philadelphia, PA), Kambayashi; Taku (Malvern, PA) |
Assignee: | The Children\'s Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA) |
Application Number: | 15/305,272 |
Patent Claims: | see list of patent claims |
Details for Patent 10,040,859
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST | rilonacept | For Injection | 125249 | 02/27/2008 | ⤷ Try a Trial | 2034-04-21 |
Novartis Pharmaceuticals Corporation | ILARIS | canakinumab | For Injection | 125319 | 06/17/2009 | ⤷ Try a Trial | 2034-04-21 |
Novartis Pharmaceuticals Corporation | ILARIS | canakinumab | Injection | 125319 | 12/22/2016 | ⤷ Try a Trial | 2034-04-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |